Diamidophosphate

Diamidophosphate

SCHEMBL43115

NP(N)(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12188 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260139250-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER BY TARGETING ONCOGENIC TRANSFER RNAS THE CHILDRENS MEDICAL CENTER CORP (US) 2026-05-21 US claimed
US-20260137797-A1 MUSCLE TARGETING COMPLEXES FOR TREATING DYSTROPHINOPATHIES DYNE THERAPEUTICS, INC. (US) 2026-05-21 US claimed
US-12630827-B2 Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies ROGCON, INC. (US) 2026-05-19 US claimed
WO-2026102280-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF KIDNEY DISEASE PYC Therapeutics Limited (AU) 2026-05-15 WO claimed
US-20260125686-A1 COMPOSITIONS AND METHODS FOR MODULATION OF CFTR CYSTIC FIBROSIS FOUND (US) 2026-05-07 US claimed
US-20260117228-A1 COMPOSITIONS AND METHODS FOR TREATING PRIMARY CILIARY DYSKINESIA SKIP THERAPEUTICS LTD (IL) 2026-04-30 US claimed
US-20260117227-A1 COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY SAREPTA THERAPEUTICS, INC. (US) 2026-04-30 US claimed
WO-2026090034-A1 AGENTS FOR TREATMENT OF OPTIC CONDITIONS Vision Pharma Pty Ltd (AU) 2026-04-30 WO claimed
US-20260109986-A1 THERAPEUTIC OLIGONUCLEOTIDES TO CORRECT CYSTIC FIBROSIS MUTATIONS UNIV NORTH CAROLINA CHAPEL HILL (US) 2026-04-23 US claimed
US-20260098262-A9 COMPOUNDS AND METHODS FOR SKIPPING EXON 44 IN DUCHENNE MUSCULAR DYSTROPHY ENTRADA THERAPEUTICS INC (US) 2026-04-09 US claimed
WO-1996040739-A2 URETHANE MEDIATED, GST SPECIFIC MOLECULAR RELEASE SYSTEMS TERRAPIN TECHNOLOGIES, INC. (US) 1996-12-19 WO claimed
US-5556942-A Glutathione S-transferase-activated compounds TERRAPIN TECHNOLOGIES, INC. (US) 1996-09-17 US claimed
US-5545621-A Glutathione S-transferase-activated compounds TERRAPIN TECHNOLOGIES, INC. (US) 1996-08-13 US claimed
EP-0721465-A1 GLUTATHIONE S-TRANSFERASE-ACTIVATED COMPOUNDS TERRAPIN TECHNOLOGIES, INC. (US) 1996-07-17 EP claimed
US-5506337-A Morpholino-subunit combinatorial library and method ANTIVIRALS INC. (US) 1996-04-09 US claimed
WO-1995009866-A1 GLUTATHIONE S-TRANSFERASE-ACTIVATED COMPOUNDS TERRAPIN TECHNOLOGIES, INC. (US) 1995-04-13 WO claimed
WO-1995009865-A1 GLUTATHIONE S-TRANSFERASE-ACTIVATED COMPOUNDS TERRAPIN TECHNOLOGIES, INC. (US) 1995-04-13 WO claimed
US-4518413-A Poly-phosphorodiamide urease inhibitors and urease inhibited urea based fertilizer compositions ALLIED CORPORATION (US) 1985-05-21 US claimed
US-4517002-A Phosphorodiamide urease inhibitors and urease inhibited urea based fertilizer compositions ALLIED CORPORATION (US) 1985-05-14 US claimed
US-3957923-A FIREPROOFING E. I. DU PONT DE NEMOURS & COMPANY (US) 1976-05-18 US claimed